Pubblicazioni 2013

  1. Arumugam P, Partelli S, Coleman SJ, Cataldo I, Beghelli S, Bassi C, Wijesuriya N, Aleong JA, Froeling FE, Scarpa A et al: Ezrin expression is an independent prognostic factor in gastro-intestinal cancers. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2013, 17(12):2082-2091.
  2. Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero M, Sperduti I et al: A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol 2013, 24(3):693-701.
  3. Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C et al: Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013, 45(2):95-99.
  4. Campos ML, Sanchez-Arevalo Lobo VJ, Rodolosse A, Gottardi CJ, Mafficini A, Beghelli S, Scardoni M, Bassi C, Scarpa A, Real FX: ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. The Biochemical journal 2013, 451(3):395-405.
  5. Capello M, Cappello P, Linty FC, Chiarle R, Sperduti I, Novarino A, Salacone P, Mandili G, Naccarati A, Sacerdote C et al: Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Journal of hematology & oncology 2013, 6(1):67.
  6. Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamo A, Tecchio C, Cassatella MA et al: The TNF-family cytokine TL1A inhibits proliferation of human activated B cells. PLoS One 2013, 8(4):e60136.
  7. Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ et al: Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies. Haematologica 2013, 98(4):626-634.
  8. Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C et al: Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol 2013, 31(10):1348-1356.
  9. Chang DK, Jamieson NB, Scarpa A, McKay CJ, Biankin AV: Reply to G.F. Arroyo. J Clin Oncol 2013, 31(30):3843-3844.
  10. Dalla Pozza E, Lerda C, Costanzo C, Donadelli M, Dando I, Zoratti E, Scupoli MT, Beghelli S, Scarpa A, Fattal E et al: Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Biochimica et biophysica acta 2013, 1828(5):1396-1404.
  11. Di Costanzo F, Falconi M, Trodella L, Reni M, Scarpa A: Linee guida AIOM: Carcinoma del pancreas esocrino. AIOM document 2013.
  12. Falco A, Rosati A, Festa M, Basile A, De Marco M, d’Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF et al: BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. The American journal of gastroenterology 2013, 108(7):1178-1180.
  13. Giovinazzo F, Malpeli G, Zanini S, Parenti M, Piemonti L, Colombatti M, Valenti MT, Dalle Carbonare L, Scarpa A, Sinnett-Smith J et al: Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction. Cellular signalling 2013, 25(3):651-659.
  14. Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S et al: Carcinogenesis of pancreatic adenocarcinoma: precursor lesions. International journal of molecular sciences 2013, 14(10):19731-19762.
  15. Gruppo di lavoro AIOM – SIAPEC-IAP, Barbareschi M, Daidone MG, Lavitrano ML, Scarpa A, Pinto C, Clemente C, Ardizzoni A, Botti G, Bravo E et al: Bio-banche oncologiche a scopo di ricerca: Definizione, finalità, organizzazione, requisiti strutturali e tecnologici, consenso informato, privacy e modalità di accesso. AIOM-SIAPEC document 2013.
  16. Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P et al: Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nature genetics 2013, 45(12):1470-1473.
  17. Lawlor RT, Sluss PM, Langer R, Sughayer MA, Igbe MA, Siddiqui K, De Blasio P, Duma B, Mendy M, Chabannon C et al: European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries. Biopreserv Biobank 2013, 11(3):176-181.
  18. Oberg K, Casanovas O, Castano JP, Chung D, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A et al: Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res 2013, 19(11):2842-2849.
  19. Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa A, Ruszniewski P, Sauvanet A, Falconi M: Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA surgery 2013, 148(10):932-939.
  20. Pedica F, Ruzzenente A, Bagante F, Capelli P, Cataldo I, Pedron S, Iacono C, Chilosi M, Scarpa A, Brunelli M et al: A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. PLoS One 2013, 8(7):e68203.
  21. Rachakonda PS, Bauer AS, Xie H, Campa D, Rizzato C, Canzian F, Beghelli S, Greenhalf W, Costello E, Schanne M et al: Somatic mutations in exocrine pancreatic tumors: association with patient survival. PLoS One 2013, 8(4):e60870.
  22. Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, Martignoni G, Bianco R, Tortora G: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer 2013, 109(3):686-693.
  23. Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CM: B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(45):18208-18213.
  24. Scarpa A, Fassan M, Rusev B, Luchini C, Capelli C: Pathologist’s role in the management of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). J Oncopathology 2013, 1(3):65-74.
  25. Scarpa A, Sikora K, Fassan M, Rachiglio AM, Cappellesso R, Antonello D, Amato E, Mafficini A, Lambiase M, Esposito C et al: Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PLoS One 2013, 8(11):e80478.
  26. Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT, Scarpa A: DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One 2013, 8(6):e62692.